FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225693600> ?p ?o ?g. }

• W4225693600 endingPage "e665" @default.
• W4225693600 startingPage "e656" @default.
• W4225693600 abstract "BackgroundInfluenza and other respiratory viruses promote Streptococcus pneumoniae proliferation in the upper respiratory tract. We sought to investigate for what we believe is the first time, the effect of intranasal live attenuated influenza vaccine (LAIV) on nasopharyngeal S pneumoniae density in a low-income to middle-income country population with high pneumococcal carriage rates.MethodsIn an open-label, randomised, controlled trial in The Gambia, 330 healthy children aged 24–59 months were randomly assigned 2:1 to receive one trivalent LAIV dose at enrolment (day 0, intervention) or at the end of active follow-up (day 21, control). The investigator team were initially masked to block size and randomisation sequence to avoid allocation bias. Group allocation was later revealed to the investigator team. The primary outcome was PCR-quantified day 7 and 21 pneumococcal density. Asymptomatic respiratory viral infection at baseline and LAIV strain shedding were included as covariates in generalised mixed-effects models, to assess the effect of LAIV and other variables on pneumococcal densities. The study is registered at ClinicalTrials.gov, NCT02972957, and is closed to recruitment.FindingsBetween Feb 8 and April 12, 2017, and Jan 15 and March 28, 2018, of 343 children assessed for eligibility, 213 in the intervention group and 108 in the control group completed the study and were included in the final analysis. Although no significant differences were seen in pneumococcal carriage or density at each timepoint when comparing groups, changes from baseline were observed in the LAIV group. The baseline S pneumoniae carriage prevalence was high in both LAIV and control groups (75%) and increased by day 21 in the LAIV group (85%, p=0·0037), but not in the control group (79%, p=0·44). An increase in pneumococcal density from day 0 amounts was seen in the LAIV group at day 7 (+0·207 log10 copies per μL, SE 0·105, p=0·050) and day 21 (+0·280 log10 copies per μL, SE 0·105, p=0·0082), but not in the control group. Older age was associated with lower pneumococcal density (−0·015 log10 copies per μL, SE 0·005, p=0·0030), with the presence of asymptomatic respiratory viruses at baseline (+0·259 log10 copies per μL, SE 0·097, p=0·017), and greater LAIV shedding at day 7 (+0·380 log10 copies per μL, SE 0·167, p=0·024) associated with higher pneumococcal density. A significant increase in rhinorrhoea was reported in the LAIV group compared with the control group children during the first 7 days of the study (103 [48%] of 213, compared with 25 [23%] of 108, p<0·0001), and between day 7 and 21 (108 [51%] of 213, compared with 28 [26%] of 108, p<0·0001).InterpretationLAIV was associated with a modest increase in nasopharyngeal pneumococcal carriage and density in the 21 days following vaccination, with the increase in density lower in magnitude than previously described in the UK. This increase was accelerated when LAIV was administered in the presence of pre-existing asymptomatic respiratory viruses, suggesting that nasopharyngeal S pneumoniae proliferation is driven by cumulative mixed-viral co-infections. The effect of LAIV on pneumococcal density is probably similar to other respiratory viral infections in children. Our findings provide reassurance for the use of LAIV to expand influenza vaccine programmes in low-income to middle-income country populations with high pneumococcal carriage.FundingWellcome Trust." @default.
• W4225693600 created "2022-05-05" @default.
• W4225693600 creator A5002378351 @default.
• W4225693600 creator A5004310215 @default.
• W4225693600 creator A5014938248 @default.
• W4225693600 creator A5017020487 @default.
• W4225693600 creator A5021989823 @default.
• W4225693600 creator A5027197819 @default.
• W4225693600 creator A5031578464 @default.
• W4225693600 creator A5033153495 @default.
• W4225693600 creator A5034304785 @default.
• W4225693600 creator A5052439930 @default.
• W4225693600 creator A5055950683 @default.
• W4225693600 creator A5060515646 @default.
• W4225693600 creator A5066422327 @default.
• W4225693600 creator A5069576329 @default.
• W4225693600 creator A5077273904 @default.
• W4225693600 creator A5083015555 @default.
• W4225693600 creator A5084006284 @default.
• W4225693600 creator A5089110165 @default.
• W4225693600 date "2021-12-01" @default.
• W4225693600 modified "2023-10-03" @default.
• W4225693600 title "The effect of live attenuated influenza vaccine on pneumococcal colonisation densities among children aged 24–59 months in The Gambia: a phase 4, open label, randomised, controlled trial" @default.
• W4225693600 cites W1912934531 @default.
• W4225693600 cites W1939920220 @default.
• W4225693600 cites W1966521561 @default.
• W4225693600 cites W2026646453 @default.
• W4225693600 cites W2095135825 @default.
• W4225693600 cites W2097230608 @default.
• W4225693600 cites W2110005071 @default.
• W4225693600 cites W2121369371 @default.
• W4225693600 cites W2146280181 @default.
• W4225693600 cites W2152692480 @default.
• W4225693600 cites W2154385325 @default.
• W4225693600 cites W2155216032 @default.
• W4225693600 cites W2156840385 @default.
• W4225693600 cites W2168613507 @default.
• W4225693600 cites W2229704027 @default.
• W4225693600 cites W2283730606 @default.
• W4225693600 cites W2619684722 @default.
• W4225693600 cites W2621893872 @default.
• W4225693600 cites W2740580350 @default.
• W4225693600 cites W2743774508 @default.
• W4225693600 cites W2767845197 @default.
• W4225693600 cites W2775569101 @default.
• W4225693600 cites W2793839645 @default.
• W4225693600 cites W2903100843 @default.
• W4225693600 cites W2913080128 @default.
• W4225693600 cites W2913763208 @default.
• W4225693600 cites W2922158324 @default.
• W4225693600 cites W2952952400 @default.
• W4225693600 cites W3032079216 @default.
• W4225693600 cites W3045011468 @default.
• W4225693600 doi "https://doi.org/10.1016/s2666-5247(21)00179-8" @default.
• W4225693600 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34881370" @default.
• W4225693600 hasPublicationYear "2021" @default.
• W4225693600 type Work @default.
• W4225693600 citedByCount "6" @default.
• W4225693600 countsByYear W42256936002022 @default.
• W4225693600 countsByYear W42256936002023 @default.
• W4225693600 crossrefType "journal-article" @default.
• W4225693600 hasAuthorship W4225693600A5002378351 @default.
• W4225693600 hasAuthorship W4225693600A5004310215 @default.
• W4225693600 hasAuthorship W4225693600A5014938248 @default.
• W4225693600 hasAuthorship W4225693600A5017020487 @default.
• W4225693600 hasAuthorship W4225693600A5021989823 @default.
• W4225693600 hasAuthorship W4225693600A5027197819 @default.
• W4225693600 hasAuthorship W4225693600A5031578464 @default.
• W4225693600 hasAuthorship W4225693600A5033153495 @default.
• W4225693600 hasAuthorship W4225693600A5034304785 @default.
• W4225693600 hasAuthorship W4225693600A5052439930 @default.
• W4225693600 hasAuthorship W4225693600A5055950683 @default.
• W4225693600 hasAuthorship W4225693600A5060515646 @default.
• W4225693600 hasAuthorship W4225693600A5066422327 @default.
• W4225693600 hasAuthorship W4225693600A5069576329 @default.
• W4225693600 hasAuthorship W4225693600A5077273904 @default.
• W4225693600 hasAuthorship W4225693600A5083015555 @default.
• W4225693600 hasAuthorship W4225693600A5084006284 @default.
• W4225693600 hasAuthorship W4225693600A5089110165 @default.
• W4225693600 hasBestOaLocation W42256936001 @default.
• W4225693600 hasConcept C126322002 @default.
• W4225693600 hasConcept C133239900 @default.
• W4225693600 hasConcept C142724271 @default.
• W4225693600 hasConcept C168563851 @default.
• W4225693600 hasConcept C187212893 @default.
• W4225693600 hasConcept C203014093 @default.
• W4225693600 hasConcept C22070199 @default.
• W4225693600 hasConcept C2776152631 @default.
• W4225693600 hasConcept C2777910003 @default.
• W4225693600 hasConcept C2778866548 @default.
• W4225693600 hasConcept C2779301066 @default.
• W4225693600 hasConcept C2780689484 @default.
• W4225693600 hasConcept C2781253189 @default.
• W4225693600 hasConcept C2908647359 @default.
• W4225693600 hasConcept C32762888 @default.
• W4225693600 hasConcept C523546767 @default.
• W4225693600 hasConcept C54355233 @default.
• W4225693600 hasConcept C71924100 @default.

• next